Atit Silsirivanit

1.6k total citations
72 papers, 1.1k citations indexed

About

Atit Silsirivanit is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Atit Silsirivanit has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 37 papers in Surgery and 19 papers in Oncology. Recurrent topics in Atit Silsirivanit's work include Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers), Glycosylation and Glycoproteins Research (30 papers) and Galectins and Cancer Biology (13 papers). Atit Silsirivanit is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers), Glycosylation and Glycoproteins Research (30 papers) and Galectins and Cancer Biology (13 papers). Atit Silsirivanit collaborates with scholars based in Thailand, Japan and United States. Atit Silsirivanit's co-authors include Sopit Wongkham, Chaisiri Wongkham, Kanlayanee Sawanyawisuth, Kulthida Vaeteewoottacharn, Chatchai Phoomak, Wunchana Seubwai, Chawalit Pairojkul, Norie Araki, Seiji Okada and Banchob Sripa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Atit Silsirivanit

67 papers receiving 1.1k citations

Peers

Atit Silsirivanit
Wunchana Seubwai Thailand
Bhuwan Giri United States
Xiao-Chun Xu United States
Xiaobing Chen China
Fujun Li China
Marjaana Säily Finland
Kecheng Zhang China
Yiwei Wang China
Lorea Mendoza Spain
Wunchana Seubwai Thailand
Atit Silsirivanit
Citations per year, relative to Atit Silsirivanit Atit Silsirivanit (= 1×) peers Wunchana Seubwai

Countries citing papers authored by Atit Silsirivanit

Since Specialization
Citations

This map shows the geographic impact of Atit Silsirivanit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atit Silsirivanit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atit Silsirivanit more than expected).

Fields of papers citing papers by Atit Silsirivanit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atit Silsirivanit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atit Silsirivanit. The network helps show where Atit Silsirivanit may publish in the future.

Co-authorship network of co-authors of Atit Silsirivanit

This figure shows the co-authorship network connecting the top 25 collaborators of Atit Silsirivanit. A scholar is included among the top collaborators of Atit Silsirivanit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atit Silsirivanit. Atit Silsirivanit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahalapbutr, Panupong, et al.. (2025). Soyasaponin-I Attenuates Melanogenesis through Activation of ERK and Suppression of PKA/CREB Signaling Pathways. ACS Omega. 10(17). 18056–18061. 1 indexed citations
2.
Silsirivanit, Atit, et al.. (2025). Discovery of bis -thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study. Journal of Enzyme Inhibition and Medicinal Chemistry. 40(1). 2518195–2518195. 1 indexed citations
3.
Vaeteewoottacharn, Kulthida, Ubon Cha’on, Chawalit Pairojkul, et al.. (2025). Clinical impacts of Artocarpus lakoocha agglutinin-binding glycans for prognosis and treatment of cholangiocarcinoma. Scientific Reports. 15(1). 436–436.
4.
5.
6.
Sutthanut, Khaetthareeya, Panupong Mahalapbutr, Wunchana Seubwai, et al.. (2022). Anserine/Carnosine-Rich Extract from Thai Native Chicken Suppresses Melanogenesis via Activation of ERK Signaling Pathway. Molecules. 27(21). 7440–7440. 7 indexed citations
7.
Thanan, Raynoo, Apinya Jusakul, Atit Silsirivanit, et al.. (2022). Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma. Clinica Chimica Acta. 536. 142–154. 4 indexed citations
8.
Silsirivanit, Atit, et al.. (2021). Antioxidant and Cytotoxic Activity of Phellinus Mushrooms from Northeast Thailand. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Luang, Sukanya, Sakda Waraasawapati, Patcharee Boonsiri, et al.. (2021). A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin. Molecules. 26(9). 2782–2782. 5 indexed citations
10.
Silsirivanit, Atit, et al.. (2021). Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment. Experimental Cell Research. 410(1). 112949–112949. 10 indexed citations
11.
Roytrakul, Sittiruk, Temduang Limpaiboon, Sopit Wongkham, et al.. (2019). Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma. Biomolecules. 9(9). 413–413. 17 indexed citations
12.
Silsirivanit, Atit, Kanlayanee Sawanyawisuth, Ubon Cha’on, et al.. (2019). Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients. Medicina. 55(12). 761–761. 16 indexed citations
13.
Vaeteewoottacharn, Kulthida, Chawalit Pairojkul, Ryusho Kariya, et al.. (2019). Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model. Cells. 8(5). 496–496. 30 indexed citations
14.
Li, Jia V., Jutarop Phetcharaburanin, Chaisiri Wongkham, et al.. (2019). Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats. Biomolecules. 9(10). 542–542. 12 indexed citations
15.
Silsirivanit, Atit. (2019). Glycosylation markers in cancer. Advances in clinical chemistry. 89. 189–213. 133 indexed citations
16.
Phoomak, Chatchai, et al.. (2017). New evidence of connections between increased O-GlcNAcylation and inflammasome in the oral mucosa of patients with oral lichen planus. Clinical & Experimental Immunology. 192(1). 129–137. 18 indexed citations
17.
Silsirivanit, Atit, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, et al.. (2017). Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis. Clinica Chimica Acta. 477. 66–71. 7 indexed citations
18.
Silsirivanit, Atit, Sopit Wongkham, Banchob Sripa, et al.. (2016). YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Tumor Biology. 37(7). 9451–9463. 21 indexed citations
19.
Silsirivanit, Atit, Norie Araki, Chaisiri Wongkham, et al.. (2013). CA‐S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Science. 104(10). 1278–1284. 30 indexed citations
20.
Silsirivanit, Atit, Siriporn Proungvitaya, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, & Sopit Wongkham. (2012). Biomarkers in Bile Duct Cancers: Current Status. Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร. 27(3). 405–412. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wunchana Seubwai Breakdown of academic impact, for papers by Bhuwan Giri Breakdown of academic impact, for papers by Xiao-Chun Xu Breakdown of academic impact, for papers by Xiaobing Chen Breakdown of academic impact, for papers by Fujun Li Breakdown of academic impact, for papers by Marjaana Säily Breakdown of academic impact, for papers by Kecheng Zhang Breakdown of academic impact, for papers by Yiwei Wang Breakdown of academic impact, for papers by Lorea Mendoza
Rankless by CCL
2026